On the other hand, coding cfDNA, such as fragments containing mutated or aberrantly expressed genes like TP53 or KRAS, can modulate immune responses indirectly by signalling tumour-derived stress or damage, thus amplifying inflammation and immune surveillance in cases such as cancer or infection [25]. This evidence concerns the gene TP53 and neoplasm.